This multicenter, open‐label trial was designed to study the safety of intravenous (IV) sodium
valproate in patients with epilepsy. All 318 patients (previously treated with antiepileptic …

Discussion The most common treatment strategy is using the appropriate AED for seizure
control as monotherapy in the lowest effective dosage throughout pregnancy. 2 VA acid …

However, after 2 months of being discharged, he presented to the emergency service with
similar complaints. Changes in sodium and potassium levels were observed. He described …

Almost 50 years after its discovery, valproic acid remains a mainstay in the treatment of
epilepsy, both alone and in combination with other anticonvulsants. It is also associated with …

Purpose: To report on pediatric patients with absence epilepsy who experienced absence
seizure aggravation while receiving valproic acid (VPA). Methods: The charts of all children …

Sodium valproate (VPA) is an anticonvulsant used in the treatment of epilepsy and bipolar
disorder. Most of its side effects are innocuous, such as transient sedation, an action and …

Background: Valproate sodium, a commonly used antiepileptic drug (AED), is effective for
the treatment of status epilepticus and is often used as a second-line agent when other …

Purpose: Valproate has been widely used in controlling various kinds of seizures.
Intravenous forms of valproate control seizures in a more rapid and efficacious pattern than …

We report the case of a 62-year-old man who was administered sodium valproate (VPA) and
who subsequently developed the syndrome of inappropriate secretion of antidiuretic …

A report of 3 cases of sodium valproate “encephalopathy”. The addition of valproate to the
treatment in 3 subjects, two adults and one child, all with generalised epilepsy, induced a …